Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAI-1678 for Postoperative Pain After Hip or Knee Replacement
NCT01015235Phase 2Completed
- Sponsor
- KAI Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Feb 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KAI-1678 in postoperative pain, sponsored by KAI Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
KAI-1678
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01015235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015235.